World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
68
Citations
16080
World Ranking
1520
National Ranking
119

Rachael Natrajan publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Rachael Natrajan sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 163 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Rachael Natrajan D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Rachael Natrajan sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 68 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Rachael Natrajan is affiliated with the Institute of Cancer Research in the United Kingdom and has contributed extensively to research in cancer biology and related fields. Their work primarily spans biochemistry, genetics, molecular biology, and medicine, with a strong focus on oncology and cancer research.

Their subfields of study include:

  • Molecular Biology
  • Oncology
  • Cancer Research
  • Pathology and Forensic Medicine
  • Pulmonary and Respiratory Medicine

Natrajan's main research topics cover an array of cancer-related areas:

  • Chromatin Remodeling and Cancer
  • Cancer Genomics and Diagnostics
  • Cancer Cells and Metastasis
  • Breast Cancer Treatment Studies
  • Cancer Mechanisms and Therapy
  • Ovarian Cancer Diagnosis and Treatment
  • Advanced Breast Cancer Therapies

Their recent publications include:

  • Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes, 2020, Cancer Discovery
  • Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors, 2020, Journal of Clinical Oncology
  • ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response, 2020, Nature Genetics
  • ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI), 2021, International Journal of Gynecological Cancer
  • Subclonal heterogeneity and evolution in breast cancer, 2021, npj Breast Cancer

Frequent co-authors who have collaborated with Natrajan include:

  • Syed Haider
  • Christopher J. Lord
  • John Alexander
  • Naomi Guppy
  • Ioanna Mavrommati

Natrajan publishes consistently in several scientific venues, with the most frequent being:

  • Cancer Research
  • Nature Genetics
  • Cancers
  • Annals of Oncology
  • npj Breast Cancer

Best Publications

  • Resistance to therapy caused by intragenic deletion in BRCA2

    Stacey L. Edwards;Rachel Brough;Christopher J. Lord;Rachael Natrajan

  • Complex landscapes of somatic rearrangement in human breast cancer genomes.

    Philip J. Stephens;David J. Mcbride;Meng-lay Lin;Ignacio Varela

  • BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells

    Gemma Molyneux;Felipe C. Geyer;Fiona-Ann Magnay;Afshan McCarthy

  • Breast cancer molecular profiling with single sample predictors: a retrospective analysis

    Britta Weigelt;Alan Mackay;Roger A'hern;Rachael Natrajan

  • Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets.

    N Turner;M B Lambros;H M Horlings;A Pearson

  • β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.

    Felipe C Geyer;Magali Lacroix-Triki;Kay Savage;Monica Arnedos

  • Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer

    Dan R. Robinson;Shanker Kalyana-Sundaram;Shanker Kalyana-Sundaram;Yi Mi Wu;Sunita Shankar

  • PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors

    Konstantin J. Dedes;Daniel Wetterskog;Ana M. Mendes-Pereira;Rachael Natrajan

  • Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma

    Munir R. Tanas;Andrea Sboner;Andre M. Oliveira;Michele R. Erickson-Johnson

  • Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity.

    Illirjana Bajrami;Jessica R. Frankum;Asha Konde;Rowan E. Miller

  • The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

    Britta Weigelt;Felipe C Geyer;Rachael Natrajan;Maria A Lopez-Garcia;Maria A Lopez-Garcia

  • Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C

    Nicola H. Dryden;Laura R. Broome;Frank Dudbridge;Nichola Johnson

  • Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes

    Matthew Clarke;Alan Mackay;Britta Ismer;Britta Ismer;Jessica Chiara Pickles

  • Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas.

    Felipe C Geyer;Britta Weigelt;Rachael Natrajan;Maryou B K Lambros

  • SF3B1 mutations constitute a novel therapeutic target in breast cancer

    Sarah L. Maguire;Andri Leonidou;Patty Wai;Caterina Marchiò;Caterina Marchiò

  • Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type

    Magali Lacroix-Triki;Paula H Suarez;Alan MacKay;Maryou B Lambros

  • Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection

    Lucia Hernandez;Paul M Wilkerson;Maryou B Lambros;Adriana Campion-Flora

  • Tiling path genomic profiling of grade 3 invasive ductal breast cancers.

    Rachael Natrajan;Maryou B. Lambros;Socorro María Rodríguez-Pinilla;Gema Moreno-Bueno

  • Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers†

    Daniel Wetterskog;Maria Angeles Lopez-Garcia;Maria Angeles Lopez-Garcia;Maryou B Lambros;Roger A'Hern

  • FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo

    Rachel Sharpe;Alex Pearson;Maria T. Herrera-Abreu;Damian A. Johnson

Frequent Co-Authors

Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Alan Ashworth
Alan Ashworth University of California, San Francisco
Alan Mackay
Alan Mackay Institute of Cancer Research
Christopher J. Lord
Christopher J. Lord Institute of Cancer Research
Chris Jones
Chris Jones Institute of Cancer Research
Anne Vincent-Salomon
Anne Vincent-Salomon Institute Curie
Charlotte K.Y. Ng
Charlotte K.Y. Ng Humanitas University
Andrew Tutt
Andrew Tutt Institute of Cancer Research
Kathy Pritchard-Jones
Kathy Pritchard-Jones University College London
Salvatore Piscuoglio
Salvatore Piscuoglio Humanitas University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology opens diverse opportunities across various sectors beyond the traditional lab or academic roles. For students interested in healthcare and counseling, online clinical psychology programs can complement a molecular background, leading to roles in mental health, genetics counseling, or research. Those looking for a broader impact on community wellbeing might consider a human services degree online, which is ideal for supporting families and individuals with science-driven approaches.

Molecular Biology graduates with teaching experience may wish to pivot their careers. Learning how to make a career change from teacher to SLP (speech pathologist) is one way to apply scientific expertise in educational and clinical settings, helping individuals with communication disorders.

Lastly, for those drawn to design and innovation, combining science with technology via online architecture programs can lead to unique careers. This merging of fields is useful in bio-inspired design, laboratory planning, and healthcare infrastructure.

Best Scientists Citing Rachael Natrajan

Trending Scientists

Recently Published Articles